The role of leucine residues in the structure and function of a leucine zipper peptide inhibitor of paramyxovirus (NDV) fusion

Virology

Volumn 243, Issue 1, 1998, Pages 21-31

  Young, John K ^a   Hicks, Rickey P ^b   Wright, George E ^a   Morrison, Trudy G ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Fusion; Molecular modeling; NDV; NMR; Paramyxovirus; Peptide

Indexed keywords

INHIBITOR PROTEIN; LEUCINE; SYNTHETIC PEPTIDE; VIRUS FUSION PROTEIN;

ANIMAL CELL; ARTICLE; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; VIRUS INHIBITION;

ANIMALIA; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; RNA VIRUSES;

EID: 0032579848     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9044     Document Type: Article

References (34)

1. Bax A., Davis D. G. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 65:1985;355-360.
2. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
3. Buckland R., Wild F. Leucine zipper motif extends. Nature (London). 338:1989;547.
4. Bull T. E. ROESY relaxation theory. J. Magn. Reson. 80:1988;470-481.
5. Chambers P., Pringle C. R., Easton J. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
6. Chen S. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68:1994;2002-2010.
7. 1. J. Mol. Biol. 186:1985;435-455.
8. Creighton T. E. Proteins: Structure and Molecular Properties. 1984;Freeman, New York.
9. deGroot R. J., Luytjes W., Horzinek M. C., Zeijst B. A. M. v. d., Spaan W. J. M., Lenstra J. A. Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J. Mol. Biol. 196:1987;963-966.
10. Dubay J. W., Roberts S. J., Brody B., Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66:1992;4748-4756.
11. Eich G., Bodenhausen G., Ernst R. R. Exploring nuclear spin systems by relayed magnetization transfer. J. Am. Chem. Soc. 104:1982.
12. Gallagher T. M., Escarmis C., Buchmeier M. J. Alteration of the pH dependence of coronavirus-induced cell fusion: Effect of mutations in the spike glycoprotein. J. Virol. 65:1991;1916-1928.
13. Glickman R. L., Syddall R. J., Sheehan R. M., Bratt M. A. Quantitative basic residue requirements in the cleavage activation site of the fusion glycoprotein as a determinant of virulence of Newcastle disease virus. J. Virol. 62:1988;354-356.
14. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Biol. 12:1996;627-661.
15. Hicks R. P., Young J. K. Magnetization transfer via isotropic mixing: An introduction to the HOHAHA experiment. Concepts Magn. Reson. 6:1994;115-130.
16. Lamb R. A. Paramyxovirus fusion: A hypothesis of changes. Virology. 197:1993;1-11.
17. Lambert D. M., Barney S., Lambert A. L., Guthrie K., Medinas R., Davis D. E., Bucy T., Erickson J., Merutka G., Petteway S. R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA. 93:1996;2186-2191.
18. Rapaport D., Ovadia M., Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses. EMBO J. 14:1995;5524-5531.
19. Reitter J., Sergel T., Morrison T. Mutational analysis of the leucine zipper motif in the Newcastle disease virus fusion protein. J. Virol. 69:1995;5995-6004.
20. Rose G. D., Gierasch L. M., Smith J. A. Turns in peptides and proteins. Adv. Protein Chem. 37:1985;1-106.
21. Scheid A., Choppin P. W. Identification of biological activities of paramyxovirus glycoproteins: Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive protein of Sendai virus. Virology. 57:1974;470-490.
22. Scheid A., Choppin P. W. Two disulfide-linked polypeptide chains constitute active F protein of paramyxoviruses. Virology. 80:1978;51-66.
23. Sergel T., McGinnes L. W., Morrison T. G. The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. Virology. 196:1993;831-834.
24. States D. J., Haberhorn R. A., Rubin D. J. A two dinemsional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 48:1982;286-292.
25. Toyoda T., Sakaguchi T., Imai K., Inocencio N. M., Gotoh G., Hamaguchi M., Nagai Y. Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology. 158:1987;242-247.
26. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Phys. 52:1990;2887-2896.
27. White J. M. Membrane fusion. Science. 258:1992;917-924.
28. Wild C., Dubay J. W., Greenwell T., T. Baird J., Oas T. G., McDanal C., Hunter E., Mathews T. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl. Acad. Sci. USA. 91:1994;12676-12680.
29. Wild C., Oas T., McDanal C., Bolognesi D., Mathews T. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:1992;10537-10541.
30. Wild T. F., Buckland R. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J. Gen. Virol. 78:1997;107-111.
31. Wüthrich K. NMR of Proteins and Nucleic Acids. 1986;Wiley, New York.
32. Wüthrich K., Billeter M., Braun W. Polypeptide secondary structure determined by nuclear magnetic resonance observation of short proton-proton distances. J. Mol. Biol. 180:1984;715-740.
33. Yao Q., Compans R. W. Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology. 223:1996;103-112.
34. Young J. K., Hicks R. P., Wright G. E., Morrison T. G. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology. 238:1997;291-304.